Related Experiment Video
Updated: Sep 18, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Gastrointestinal-related side effects are key barriers to dietary fiber intake
Dorsa Hosseininasab1,2, Soumodip Pal3, Sam R Emerson2
1Health Promotion Sciences, Hudson College of Public Health, University of Oklahoma Health Sciences, Tulsa, OK, USA.
Abstract:
Background: Dietary fiber intake has been consistently low, and the reasons for this are not fully understood. Acute increases in dietary fiber intake are often expected to cause gastrointestinal (GI)-related effects which may preclude regular intake, especially in individuals who are sensitive to discomfort or tend to avoid unpleasant physical sensations. Aim: Describe knowledge of, and barriers related to dietary fiber intake in adults, including GI-related side effects. Methods: A survey was sent to United States adults (N = 132; mean age = 41.3 ± 15.4 years; 72% female) with questions assessing dietary fiber knowledge and barriers, along with the Discomfort Intolerance Scale (DIS) and Behavioral Inhibition Scale/Behavioral Activation Scale (BIS/BAS). Results: Most participants (N = 132) were aware of recommendations for and sources of dietary fiber. GI-related side effects, notably flatulence, were reported by nearly half (44.7%). Reporting a GI-related side effect was significantly related to BIS scores, BAS Reward Responsive subscale scores, and DIS Intolerance subscale scores (all p ≤ 0.02). Conclusion: For some, GI-related barriers are key factors influencing dietary fiber intake.
More Related Videos
05:14Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...